ArticleCancers2022

Interpatient Heterogeneity in Drug Response and Protein Biomarker Expression of Recurrent Ovarian Cancer.

Oliver Ingo Hoffmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.